Skip to Main Content

Paper Details

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.
BMJ Med
3
2023
T2DM, antihyperglycaemic, cardiovascular disease, dipeptidyl peptidase-4, glucagon-like peptide-1 receptor, glucose, metformin, patients, people, sodium, sodium-, sodium-glucose cotransporter, sodium-glucose cotransporter-2, sulfonylureas, type 2 diabetes mellitus
Author NameAffiliation
Rohan KheraYale University
Rohan KheraYale University School of Public Health
Rohan KheraCenter for Outcomes Research and Evaluation, Yale New Haven Hospital
Rohan KheraYale University
Rohan KheraYale University School of Public Health
Rohan KheraCenter for Outcomes Research and Evaluation, Yale New Haven Hospital
Lovedeep Singh DhingraYale University
Arya AminorroayaYale University
Kelly LiFielding School of Public Health, University of California Los Angeles
Jin J ZhouFielding School of Public Health, University of California Los Angeles
Jin J ZhouDavid Geffen School of Medicine, University of California Los Angeles
Faaizah ArshadFielding School of Public Health, University of California Los Angeles
Clair Blacketer
Mary G BowringJohns Hopkins University School of Medicine
Fan BuFielding School of Public Health, University of California Los Angeles
Michael CookJohns Hopkins University School of Medicine
David A DorrDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University School of Medicine
Talita Duarte-SallesFundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol)
Talita Duarte-SallesFundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol)
Scott L DuVall
Scott L DuVallThe University of Utah School of Medicine
Scott L DuVall
Scott L DuVallThe University of Utah School of Medicine
Thomas FalconerColumbia University
Thomas FalconerColumbia University
Tina E FrenchTennessee Valley Healthcare System, Veterans Affairs Medical Center
Tina E FrenchVanderbilt University Medical Center
Elizabeth E HanchrowTennessee Valley Healthcare System, Veterans Affairs Medical Center
Elizabeth E HanchrowVanderbilt University Medical Center
Scott HorbanUniversity of Dundee
Wallis C Y LauSchool of Pharmacy, University College London
Wallis C Y Lau
Wallis C Y LauUniversity of Hong Kong
Wallis C Y LauUniversity College London Hospitals NHS Foundation Trust
Jing Li
Yuntian LiuYale University
Yuntian LiuCenter for Outcomes Research and Evaluation, Yale New Haven Hospital
Yuan LuYale University
Kenneth Kc ManSchool of Pharmacy, University College London
Kenneth Kc Man
Kenneth Kc ManUniversity of Hong Kong
Kenneth Kc ManUniversity College London Hospitals NHS Foundation Trust
Michael MathenyTennessee Valley Healthcare System, Veterans Affairs Medical Center
Michael MathenyVanderbilt University Medical Center
Nestoras MathioudakisThe Johns Hopkins University School of Medicine
Michael F McLemoreTennessee Valley Healthcare System, Veterans Affairs Medical Center
Michael F McLemoreVanderbilt University Medical Center
Evan MintyO'Brien Institute for Public Health, University of Calgary
Daniel R MoralesUniversity of Dundee
Paul NagyJohns Hopkins University School of Medicine
  • 1 - 50

Datasets